Long intergenic non-protein coding RNA 237 (LINC00237)

Long intergenic non-protein coding RNA 237 (LINC00237) is a long non-coding RNA (lncRNA) gene located on chromosome 20 (20q11.23)[7]. Unlike protein-coding genes, LINC00237 does not encode a protein but instead represents a class of regulatory RNA molecules whose functions are not fully characterized. Research suggests LINC00237 might serve as a candidate gene associated with MOMO syndrome, yet there is presently little evidence establishing it as a direct therapeutic target or as having a defined role in common disease pathways such as cancer or inflammation[5][1][3][7]. Supporting Details and Context: - Naming and Aliases: The gene is officially named "long intergenic non-protein coding RNA 237," with HGNC ID HGNC:38166 and primary abbreviation LINC00237[1][7]. It is also known as NCRNA00237[7]. - Molecular Classification: Classified as a long non-coding RNA (lncRNA), part of the “non-protein coding RNA” group[1][3][7]. It is not a receptor, enzyme, transporter, or traditional drug target. - Therapeutic Target Status: There is no evidence that LINC00237 is currently considered a direct therapeutic target in drug development or clinical research databases, nor is there information about interacting drugs or approved mechanisms of action[5][1][7]. - Disease Role: LINC00237 is noted as a candidate gene for MOMO syndrome based on a described chromosomal translocation, but is not linked to major pathways or large-scale evidence for a role in more common diseases such as cancer or inflammation[5]. - Functions: The biological roles of LINC00237 remain largely uncharacterized in the literature. Like other lncRNAs, potential functions are likely regulatory, but no specific regulatory pathway is detailed in current widely-accepted databases[3][7]. - Biomarkers and Safety: There are no mentioned uses of LINC00237 as a biomarker for disease, therapy selection, or as a predictor of therapeutic efficacy. No safety or therapeutic development concerns are documented[1][5][7]. - Gene Location: Chromosome 20: position 21,057,376-21,063,153 (GRCh38)[7]. - General Use: It is not considered a classical molecular "target" in therapeutic contexts (i.e., not a protein, enzyme, receptor, or channel that drugs act on)[1][3]. If further research clarifies the functional or therapeutic relevance of LINC00237, these entries should be updated accordingly.

Other names

NCRNA00237LINC00237